Selected Grants
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal Melanoma
Clinical TrialPrincipal Investigator · Awarded by Aura Biosciences, Inc. · 2024 - 2029Retinoblastoma Patient Clinical Database and Tissue Repository
ResearchPrincipal Investigator · Awarded by Children's Hospital Los Angeles · 2024 - 2025External Relationships
- Castle Biosciences
- Ideaya Biosciences
- LV Liberty Vision Corporation
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.